Accustem Sciences Inc. (ACUT)
USD 0.24
(0.0%)
USD 0.24
(0.0%)
| Breakdown | 2022 | 2021 |
|---|---|---|
| Revenue | - | - |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | 3.74 Million | 670.61 Thousand |
| Selling, General and Administrative Expenses | 3.47 Million | 597.27 Thousand |
| Research and Development Expenses | 266.93 Thousand | 73.33 Thousand |
| Other Expenses | - | - |
| Cost and Expenses | 3.74 Million | 670.61 Thousand |
| Operating Income | -3.74 Million | -670.61 Thousand |
| Interest Expense | - | - |
| Income Tax Expense | - | - |
| Earnings before Tax | -3.74 Million | -670.61 Thousand |
| Net Income | -3.74 Million | -670.61 Thousand |
| Earnings Per Share Basic | -0.34 | -0.07 |
| Earnings Per Share Diluted | -0.34 | -0.07 |
| Weighted Average Shares Outstanding | 11.01 Million | 9.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.01 Million | 9.99 Million |
| Gross Margin | - | - |
| EBIT Margin | - | - |
| Profit Margin | - | - |
| EBITDA | -3.74 Million | -670.61 Thousand |
| Earnings Before Tax Margin | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 598.52 Thousand | 372.75 Thousand | 833.34 Thousand | 978.53 Thousand | 3.74 Million | 899.12 Thousand |
| Selling, General and Administrative Expenses | 578.57 Thousand | 358.18 Thousand | 817.73 Thousand | 845.41 Thousand | - | 840.85 Thousand |
| Research and Development Expenses | 19.95 Thousand | 14.57 Thousand | 15.6 Thousand | 133.12 Thousand | - | 58.27 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 598.52 Thousand | 372.75 Thousand | 833.34 Thousand | 978.53 Thousand | 3.74 Million | 899.12 Thousand |
| Operating Income | -598.52 Thousand | -372.75 Thousand | 833.34 Thousand | 676.02 Million | -3.74 Million | -899.12 Thousand |
| Interest Expense | - | - | 1.66 Million | 677 Million | - | - |
| Income Tax Expense | - | - | 1.66 Million | 677 Million | - | - |
| Earnings before Tax | -598.52 Thousand | -372.75 Thousand | -833.34 Thousand | -978.53 Thousand | -3.74 Million | -899.12 Thousand |
| Net Income | -598.52 Thousand | -372.75 Thousand | -2.5 Million | -677.97 Million | -3.74 Million | -899.12 Thousand |
| Earnings Per Share Basic | -0.05 | -0.03 | -0.22 | -61.54 | - | -0.08 |
| Earnings Per Share Diluted | -0.05 | -0.03 | -0.22 | -61.54 | - | -0.08 |
| Weighted Average Shares Outstanding | 11.34 Million | 11.34 Million | 11.34 Million | 11.01 Million | 11.01 Million | 11.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.34 Million | 11.34 Million | 11.34 Million | 11.01 Million | 11.01 Million | 11.33 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -598.52 Thousand | -372.75 Thousand | 833.34 Thousand | -978.53 Thousand | - | -899.12 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
ARS
301176
000039
EFSG
601991
336260